Evidence map›Paper›PMID 17397547›Full record

ArticleBMC physiology2007

Regulatory network of inflammation downstream of proteinase-activated receptors.

Ricardo Saban, Michael R D'Andrea, Patricia Andrade-Gordon, Claudia K Derian, Igor Dozmorov, Michael A Ihnat, Robert E Hurst, Cindy Simpson, Marcia R Saban

Open access · hybridAbstract read
In one paragraph

Article in BMC physiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation.American journal of respiratory cell and molecular biology · 2014
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ricardo SabanDepartment of Physiology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. ricardo-saban@ouhsc.edu
Michael R D'Andrea
Patricia Andrade-Gordon
Claudia K Derian
Igor Dozmorov
Michael A Ihnat
Robert E Hurst
Cindy Simpson
Marcia R Saban
University of Oklahoma Health Sciences Center · USSpringhouse · USOklahoma Medical Research Foundation · US

Funding

LPS-PEPTIDE INTERACTION IN BLADDER INFLAMMATIONR01DK055828 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SABAN, RICARDO · 1998 to 2007
$2.1M
Bladder transcriptome in experimental inflammationR01DK066101 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI SABAN, RICARDO · 2003 to 2007
$1.3M
Bladder transcriptome in experimental inflammationR56DK066101 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI SABAN, RICARDO · 2009 to 2009
$355k
NIDDK NIH HHS DK066101-01NIDDK NIH HHS DK 55828-01NIDDK NIH HHS R01 DK055828NIDDK NIH HHS R01 DK066101NIDDK NIH HHS R56 DK066101
6 · The paper itself

Abstract

backgroundProtease-activated receptors (PAR) are present in the urinary bladder, and their expression is altered in response to inflammation. PARs are a unique class of G protein-coupled that carry their own ligands, which remain cryptic until unmasked by proteolytic cleavage. Although the canonical signal transduction pathway downstream of PAR activation and coupling with various G proteins is known and leads to the rapid transcription of genes involved in inflammation, the effect of PAR activation on the downstream transcriptome is unknown. We have shown that intravesical administration of PAR-activating peptides leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P (SP), and antigen was strongly attenuated by PAR1- and to a lesser extent by PAR2-deficiency.

resultsHere, cDNA array experiments determined inflammatory genes whose expression is dependent on PAR1 activation. For this purpose, we compared the alteration in gene expression in wild type and PAR1-/- mice induced by classical pro-inflammatory stimuli (LPS, SP, and antigen). 75 transcripts were considered to be dependent on PAR-1 activation and further annotated in silico by Ingenuity Pathways Analysis (IPA) and gene ontology (GO). Selected transcripts were target validated by quantitative PCR (Q-PCR). Among PAR1-dependent transcripts, the following have been implicated in the inflammatory process: b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2, and tnfaip2. However, a balanced response to signals of injury requires a transient cellular activation of a panel of genes together with inhibitory systems that temper the overwhelming inflammation. In this context, the activation of genes such as dusp1 and nfkbia seems to counter-balance the inflammatory response to PAR activation by limiting prolonged activation of p38 MAPK and increased cytokine production. In contrast, transcripts such as arf6 and dcnt1 that are involved in the mechanism of PAR re-sensitization would tend to perpetuate the inflammatory reaction in response to common pro-inflammatory stimuli.

conclusionThe combination of cDNA array results and genomic networks reveals an overriding participation of PAR1 in bladder inflammation, provides a working model for the involvement of downstream signaling, and evokes testable hypotheses regarding the transcriptome downstream of PAR1 activation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestation of cystitis.

Indexed as

Gene Expression RegulationAnimalsAntigensCalciumChromatinCystitisFemaleGene ExpressionGenomeImmunoprecipitationLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutOligonucleotide Array Sequence AnalysisPhospholipases AAntigensCalciumChromatinLipopolysaccharidesPhospholipases AReceptor, PAR-1Substance P

Identifiers

PMID17397547
PMCPMC1853107
OpenAlexW2016211878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.